Cutting edge diagnostics in rheumatology: The role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology
Open Access
- 5 April 2004
- journal article
- review article
- Published by Wiley in Arthritis Care & Research
- Vol. 51 (2) , 291-298
- https://doi.org/10.1002/art.20229
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- IgG subclass distribution of antibodies against β2‐GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associationsRheumatology, 2001
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- The Association of Anti-Ro52 Autoantibodies with Myositis and Scleroderma AutoantibodiesJournal of Autoimmunity, 1999
- Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti‐proteinase 3 and anti‐myeloperoxidase autoantibodiesJournal of Internal Medicine, 1998
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Measurement of increases in anti‐double‐stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosusArthritis & Rheumatism, 1990
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Specificity of the Crithidia luciliae method for detecting anti-DNA antibodies. Effect of absorption for lipoproteinsImmunological Investigations, 1985
- A Non-Anti-DNA Antibody Detected with theCrithidia luciliaeAnti-DNA AssayNew England Journal of Medicine, 1980